Paris - Delayed Quote EUR

BIO-UV Group S.A. (ALTUV.PA)

2.2900 -0.0900 (-3.78%)
At close: April 26 at 5:35 PM GMT+2
Key Events
Loading Chart for ALTUV.PA
DELL
  • Previous Close 2.3800
  • Open 2.3900
  • Bid --
  • Ask --
  • Day's Range 2.2500 - 2.3900
  • 52 Week Range 2.1600 - 4.5000
  • Volume 8,416
  • Avg. Volume 32,049
  • Market Cap (intraday) 23.059M
  • Beta (5Y Monthly) 0.41
  • PE Ratio (TTM) 229.00
  • EPS (TTM) 0.0100
  • Earnings Date Jul 17, 2024 - Jul 22, 2024
  • Forward Dividend & Yield 0.06 (2.62%)
  • Ex-Dividend Date Sep 27, 2023
  • 1y Target Est 4.50

BIO-UV Group S.A. designs, manufactures, and markets ultraviolet light water treatment and surface disinfectant devices for individuals and professionals in France, rest of Europe, Asia, the Middle East, the United States, and internationally. It offers O'Clear UV treatment, a disinfection system for water; DELTA-UV, a disinfection system for pools and spas; BIO-UV INOX for a chlorine-free water treatment; BIO-UV COMBIPOOL, an automatic injection and pH regulation for pools; BIO-UV REGUL pH for pools to maintain pH levels; and BIO-UV TEMPO for pools to control the duration of daily remanent injections according to water temperature. The company also provides MP Touch Screen and MPL Super Deluxe for the dechloramination of commercial and semi-commercial pools; DW for the production of drinking water; RW for the tertiary treatment of municipal wastewater disinfection; RW, IAM, and IBP for the treatment of industrial process water; BIO-SEA for the treatment of ballast water on ships; BIO-SUN for water disinfection in remote areas; and BIO-UV Kit UV Home3 3F for domestic water treatment. In addition, it offers HDPE HO/AM for the treatment of aquaculture, fish farming, and leisure ponds water; and UV AND UV HO for the treatment of water in aquariums, zoos, and ocean parks. Further, the company provides BIO-SCAN LIGHT for disinfecting surfaces in communities, medical, commercial and public places, and maritime sector. BIO-UV Group S.A. was founded in 2000 and is headquartered in Lunel, France.

www.bio-uv.com

160

Full Time Employees

December 31

Fiscal Year Ends

Related News

Performance Overview: ALTUV.PA

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

ALTUV.PA
6.34%
CAC 40
7.23%

1-Year Return

ALTUV.PA
35.58%
CAC 40
7.39%

3-Year Return

ALTUV.PA
61.55%
CAC 40
29.25%

5-Year Return

ALTUV.PA
37.04%
CAC 40
45.53%

Compare To: ALTUV.PA

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ALTUV.PA

Valuation Measures

Annual
As of 4/26/2024
  • Market Cap

    23.06M

  • Enterprise Value

    48.21M

  • Trailing P/E

    230.59

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.54

  • Price/Book (mrq)

    0.70

  • Enterprise Value/Revenue

    1.12

  • Enterprise Value/EBITDA

    20.96

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.72%

  • Return on Assets (ttm)

    3.33%

  • Return on Equity (ttm)

    7.67%

  • Revenue (ttm)

    51.29M

  • Net Income Avi to Common (ttm)

    2.42M

  • Diluted EPS (ttm)

    0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.98M

  • Total Debt/Equity (mrq)

    90.11%

  • Levered Free Cash Flow (ttm)

    -8.89M

Research Analysis: ALTUV.PA

Analyst Price Targets

4.00
4.50 Average
2.2900 Current
4.90 High
 

Fair Value

 

Company Insights: ALTUV.PA

People Also Watch